Skip to content

Author

Pranay Wal

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Molecular Engineering of Metallic Nanoparticle Using Natural Flavonoids: From Synthesis to Biological Evaluation.

INTRODUCTION Parkinson's disease (PD) is a progressive neurodegenerative disorder driven by oxidative stress, neuroinflammation, and mitochondrial dysfunction. Although flavonoids such as luteolin and fisetin exhibit strong antioxidant and neuroprotective properties, their therapeutic utility is limited by poor solubil...

Namra Aziz, Gagandeep Singh Basra, A. Wal et al. · 0 citations
Review Sep 2026

Artificial Intelligence-Driven Gene Delivery Systems in Dementia: A Comprehensive Review of Mechanisms, Tools, and Therapeutic Strategies.

INTRODUCTION/OBJECTIVE The progressive nature of dementia is represented by a reduction in two or more cognitive functions, including language, memory, executive and visuospatial functioning, personality, and behavior. Only symptoms can be alleviated by traditional medication therapies. A strategy that shows promise fo...

A. Wal, M. Shukla, Pranay Wal et al. · 0 citations
Review Sep 2026

Harnessing the Power of Large Language Models for Drug Discovery: A Systematic Review of Current Applications and Future Directions.

INTRODUCTION The demand for inventive approaches to drug discovery has increased due to the rising costs, time, and failure rates in pharmaceutical research. Large Language Models (LLMs), with their sophisticated natural language processing and generative capabilities, have become potent instruments that have the poten...

Pranay Wal, M. Shukla, Kritika Sachan et al. · 0 citations
Review Aug 2026

Advancing Pharmacovigilance: AI and Deep Learning Approaches to Detect Adverse Drug Reactions from Big Data

The results indicate the potential for substantial improvements in current pharmacovigilance systems through the use of AI-based models that can identify latent relationships and deliver safety alerts in near-real time.

C. R. Darwin, Meruva Sathish Kumar, S. Marakatham et al. · 0 citations
Review Jul 2026

Nanocarrier-based Drug Delivery Targeting GPCRs: Challenges, Clinical Translation, and Future Prospects for Precision Medicine

Novel instruments, such as artificial intelligence, molecular modelling, and systems pharmacology, may further aid the optimisation of ligand selection, carrier design, and personalised therapeutic development in GPCR-targeted therapeutic treatments.

Pranay Wal, Jyotsana Dwivedi, K. Khairunnisa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.